時代中國控股擬要約購買2021年票據 購買價為每1000美元本金額1008美元
格隆匯9月17日丨時代中國控股(01233.HK)公佈,公司現提出要約,按2021年到期的6.25%優先票據(“2021年票據”)每1000美元本金額1008美元的購買價以現金購買最多為最高接納金額的發行在外2021年票據。2021年票據的未償還本金額5億美元。
公司目前意向為,最高接納金額將為未償還本金額與新發行金額的較低者,惟公司保留權利全權酌情釐定其根據要約接納購買的2021年票據金額遠高於或遠低於最高接納金額,或完全不接納該等票據。公司已於今天向合資格持有人提出購買要約,當中載列(其中包括)要約條款、新發行條件及其他要約條件。
要約為公司積極管理其資產負債表負債及優化其債務架構政策的一部分。瑞銀、瑞信、德意志銀行及中信里昂證券擔任要約的交易商管理人,而D.F.KingLtd.則擔任要約的資訊及交付代理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.